You are here

  • Home
  • Impact
  • Publications
  • The cost-effectiveness of ibandronate in the treatment of postmenopausal osteoporosis in the US

The cost-effectiveness of ibandronate in the treatment of postmenopausal osteoporosis in the US

Earnshaw, S., Graham, C., Amonkar, MM., & Barr, CE. (2006). The cost-effectiveness of ibandronate in the treatment of postmenopausal osteoporosis in the US. Value in Health, 9(3), A163-A163.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Chapter

Food acquisition coping strategies used by food insecure adults in New Jersey
Article

The impact of using low-saline oilfield produced water for irrigation on water and soil quality in California
Article

Electrochemical carbon dioxide reduction to isopropanol using novel carbonized copper metal organic framework derived electrodes
Article

What influences evidence-based treatment sustainment after implementation support ends? A mixed method study of the adolescent-community reinforcement approach

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept